VIDEO: Don’t leave PKI analysis behind in lung cancer immunotherapy
In this video, James Stevenson, MD, a medical oncologist and hematologist at Cleveland Clinic, highlighted findings from the PIONeeR trial, which was presented at ESMO Virtual Congress 2020.
“Pharmacokinetics is worthy of a bit more study in immunotherapies because ...some of [us] think that pharmacokinetics might not matter as much as they do with chemo-therapeutics,” Stevenson said. “But it may turn out that PKI analyses are important for immunotherapies as well.”
- Barlesi F, et al. Abstract LBA53. Presented at: European Society for Medical Oncology Virtual Congress 2020; Sept. 19-21, 2020.